このエントリーをはてなブックマークに追加
ID 13351
Sort Key
2
フルテキストURL
Thumnail 118_99.pdf 5.33 MB
著者
安原 隆雄 岡山大学大学院医歯薬学総合研究科
新郷 哲郎 岡山大学大学院医歯薬学総合研究科
小林 和樹 岡山大学大学院医歯薬学総合研究科
竹内 亮 岡山大学大学院医歯薬学総合研究科
矢野 昭正 岡山大学大学院医歯薬学総合研究科
村岡 賢一郎 岡山大学大学院医歯薬学総合研究科
亀田 雅博 岡山大学大学院医歯薬学総合研究科
元 文姫 岡山大学大学院医歯薬学総合研究科
早瀬 仁志 岡山大学大学院医歯薬学総合研究科
上利 崇 岡山大学大学院医歯薬学総合研究科
松井 利浩 岡山大学大学院医歯薬学総合研究科
三好 康之 岡山大学大学院医歯薬学総合研究科
伊達 勲 岡山大学大学院医歯薬学総合研究科 ORCID 科研費研究者番号 publons
キーワード
カプセル化細胞移植
グリア細胞株由来神経栄養因子 (GDNF)
血管内皮成長因子 (VEGF)
脳虚血
パーキンソン病
備考
平成17年度岡山医学会賞(新見賞)受賞論文
出版物タイトル
岡山医学会雑誌
発行日
2006-09-01
118巻
2号
出版者
岡山医学会
出版者(別表記)
Okayama Medical Association
開始ページ
99
終了ページ
103
ISSN
0030-1558
NCID
AN00032489
資料タイプ
学術雑誌論文
OAI-PMH Set
岡山大学
言語
Japanese
著作権者
Copyright© 岡山医学会
論文のバージョン
publisher
査読
有り
DOI
NAID
Eprints Journal Name
joma
参考文献
1) Reynolds BA, Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (1992) 255, 1707-1710.
2) Goldman S: Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol (2005) 23, 862-871.
3) Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M, Hayashi H, Imazato T, Kawasaki H, Suemori H, Omachi S, Iida H, Itoh N, Nakatsuji N, Sasai Y, Hashimoto N: Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest (2005) 115, 102-109.
4) Vogel G: Cell biology. Ready or not? Human ES cells head toward the clinic. Science (2005) 308, 1534-1538.
5) Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, Martinello M, Cattalini A, Bergami A, Furlan R, Comi G, Constantin G, Martino G: Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature (2005) 436, 266-271.
6) Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom C, Andersson A: Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 344, 1402-1404.
7) Tibell A, Rafael E, Wennberg L, Nordenstrom J, Bergstrom M, Geller RL, Loudovaris T, Johnson RC, Brauker JH, Neuenfeldt S, Wernerson A: Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans. Cell Transplant (2001) 10, 591-599.
8) Aebischer P, Schluep M, Deglon N, Joseph JM, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE: Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med (1996) 2, 696-699.
9) Buchser E, Goddard M, Heyd B, Joseph JM, Favre J, de Tribolet N, Lysaght M, Aebischer P: Immunoisolated xenogenic chromaffin cell therapy for chronic pain; Initial clinical experience. Anesthesiology (1996) 85, 1005-1012; discussion 29A-30A.
10) Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I: Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci (2004) 19, 1494-1504.
11) Yasuhara T, Shingo T, Muraoka K, Wen Ji Y, Kameda M, Takeuchi A, Yano A, Nishio S, Matsui T, Miyoshi Y, Hamada H, Date I: The differences between high and lowdose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model. Brain Res (2005) 1038, 1-10.
12) Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I: Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res (2005) 1053, 10-18.
13) Yano A, Shingo T, Takeuchi A, Yasuhara T, Kobayashi K, Takahashi K, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I: Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg (2005) 103, 104-114.
14) Date I, Shingo T, Yoshida H, Fujiwara K, Kobayashi K, Ohmoto T: Grafting of encapsulated dopamine-secreting cells in Parkinson's disease; long-term primate study. Cell Transplant (2000) 9, 705-709.
15) Fujiwara K, Date I, Shingo T, Yoshida H, Kobayashi K, Takeuchi A, Yano A, Tamiya T, Ohmoto T: Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats. J Neurosurg (2003) 99, 1053-1062.
16) Shingo T, Date I, Yoshida H, Ohmoto T: Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res (2002) 69, 946-954.
17) Yoshida H, Date I, Shingo T, Fujiwara K, Kobayashi K, Miyoshi Y, Ohmoto T: Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. J Neurosurg (2003) 98, 874-881.
18) Kobayashi K, Yasuhara T, Agari T, Muraoka K, Kameda M, Wen Ji Y, Hayase H, Miyoshi Y, Matsui T, Shingo T, Date I: Control of dopamine-secretion by Tet-Off system in an in vivo model of Parkinsonian rat. Brain Res Mol Brain Res (2006) in press.
19) Gill SS, Patel NK, Hotton GR, O' Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med (2003) 9, 589-595.
20) Aoi M, Date I, Tomita S, Ohmoto T: GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration. Acta Neurochir (2000) 142, 805-810.
21) Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER Jr, Lozano AM, Penn RD, Simpson RK Jr, Stacy M, Wooten GF: Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology (2003) 60, 69-73.
22) Patel NK, Bunnage M, Plaha P, Svendsen CN, Heywood P, Gill SS: Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD; a two-year outcome study. Ann Neurol (2005) 57, 298-302.
23) Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B: Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg (2005) 102, 216-222.
24) Love S, Plaha P, Patel NK, Hotton GR, Brooks DJ, Gill SS: Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med (2005) 11, 703-704.
25) Aoi M, Date I, Tomita S, Ohmoto T: Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system. Neurol Res (2000) 22, 832-836.
26) Date I, Aoi M, Tomita S, Collins F, Ohmoto T: GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice. Neuroreport (1998) 9, 2365-2369.
27) Date I, Shingo T, Yoshida H, Fujiwara K, Kobayashi K, Takeuchi A, Ohmoto T: Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats. Cell Transplant (2001) 10, 397-401.
28) Yasuhara T, Shingo T, Muraoka K, Kobayashi K, Takeuchi A, Yano A, Wenji Y, Kameda M, Matsui T, Miyoshi Y, Date I: Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. J Neurosurg (2005) 102, 80-89.
29) 安原隆雄, 新郷哲郎, 村岡賢一郎, 亀田雅博, 元文姫, 松井利浩, 三好康之, 張捷, 野元正弘, 伊達勲: 臨床応用をめざしたパーキンソン病に対するカブ. セル化GDNF産生細胞移植の検討.Progress in Medicine (2004) 24, 270-474.
30) Kitagawa H, Sasaki C, Sakai K, Mori A, Mitsumoto Y, Mori T, Fukuchi Y, Setoguchi Y, Abe K: Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (1999) 19, 1336-1344.
31) Borlongan CV, Hadman M, Sanberg CD, Sanberg PR: Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke (2004) 35, 2385-2389.
32) Katsuragi S, Ikeda T, Date I, Shingo T, Yasuhara T, Mishima K, Aoo N, Harada K, Egashira N, Iwasaki K, Fujiwara M, Ikenoue T: Implantation of encapsulated glial cell line-derived neurotrophic factor-secreting cells prevents long-lasting learning impairment following neonatal hypoxic-ischemic brain insult in rats. Am J Obstet Gynecol (2005) 192, 1028-1037.
33) Katsuragi S, Ikeda T, Date I, Shingo T, Yasuhara T, Ikenoue T: Grafting of glial cell line-derived neurotrophic factor secreting cells for hypoxic-ischemic encephalopathy in neonatal rats. Am J Obstet Gynecol (2005) 192, 1137-1145.